Coronary Artery Disease and Myocardial Infarction

Kensuke Nishimiya , Jun Takahashi , Kazuma Oyama , et al

Read time: 15 Mins

Marinela Beznă , Gabriela Mitoaica , Lorena Ungureanu , et al

Read time: 1 Min
Dietary Sodium Intake and Atherosclerosis

Jonas Wuopio,

Watch time: 3m 1s
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)

Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al

Hans-Willi Breuer ,

Remo Albiero ,

Astrid Hubert , Andreas Seitz , Valeria Martínez Pereyra , et al

Kevin Cheng , Paul Sainsbury , Michael Fisher , et al

Yukiko Isekame , Sabiha Gati , Jose Antonio Aragon-Martin , et al

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)

Alberto Lorenzatti , Peter P Toth ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Kerry Layne , Albert Ferro ,

Julia Sikorska , James Uprichard ,

Media

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2m 29s

Watch time: 1h 7m 2s (4 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

Watch time: 3m 12s
RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

Watch time: 10m 53s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

Watch time: 17m 13s

Media

Dietary Sodium Intake and Atherosclerosis

Jonas Wuopio,

Watch time: 3m 1s
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46:28
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3m 22s
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2m 29s

Watch time: 1h 7m 2s (4 videos)
EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx

Giuseppe Tarantini,

Watch time: 5m 9s
4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Erin D Michos,

Watch time: 7m 9s

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events

Paul M Ridker,

Watch time: 10m 24s
ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a)

Steven E Nissen,

Watch time: 3m 31s
ACC 22: Results from the TRANSLATE-TIMI 70 Trial

Watch time: 3m 54s
UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

Watch time: 3m 12s
RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

Watch time: 10m 53s
EuroPCR 21: The EBC Main Study

David Hildick-Smith,

Watch time: 10m 17s
ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall,

Watch time: 9m 1s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

Watch time: 17m 13s
ESC 2020: APOC-III Reduction in Cardiovascular Disease

Jean-Claude Tardif,

View From The Thoraxcenter: What's Hot at ESC 2020

Nicolas M Van Mieghem, Joost Daemen,

Articles

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap

Aarti Thakkar

,

Anandita Agarwala

,

Erin D Michos

,

Published:

08 November 2021

Citation:

European Cardiology Review 2021;16:e41.

DOI:

https://doi.org/10.15420/ecr.2021.24
  • Views: Views 2230
  • Downloads: Downloads 106
  • Citations: 3

ISCHEMIA Trial: Key Questions and Answers

José López-Sendón

,

Raul Moreno

,

Juan Tamargo

,

Published:

14 September 2021

Citation:

European Cardiology Review 2021;16:e34.

DOI:

https://doi.org/10.15420/ecr.2021.16
  • Views: Views 4679
  • Downloads: Downloads 265
  • Citations: 1

The Role of C-reactive Protein in Patient Risk Stratification and Treatment

Ramón Arroyo-Espliguero

,

María Carmen Viana-Llamas

,

Alberto Silva-Obregón

,

Pablo Avanzas

,

Published:

07 July 2021

Citation:

European Cardiology Review 2021;16:e28.

DOI:

https://doi.org/10.15420/ecr.2020.49
  • Views: Views 2899
  • Downloads: Downloads 185
  • Citations: 2

APSC Consensus Recommendations on High-risk Chronic Coronary Syndrome

Jack Wei Chieh Tan

,

Derek P Chew

,

David Brieger

,

John Eikelboom

,

Gilles Montalescot

,

Junya Ako

,

Byeong-Keuk Kim

,

David Quek

,

Sarah J Aitken

,

Clara K Chow

,

Sok Chour

,

Hung-Fat Tse

,

Upendra Kaul

,

Isman Firdaus

,

Takashi Kubo

,

Boon Wah Liew

,

Tze Tec Chong

,

Kenny Yoong Kong Sin

,

Hung-I Yeh

,

Wacin Buddhari

,

Narathip Chunhamaneewat

,

Faisal Hasan

,

Keith AA Fox

,

Quang Ngoc Nguyen

,

Sidney TH Lo

,

Published:

18 June 2021

Citation:

European Cardiology Review 2021;16:e26.

DOI:

https://doi.org/10.15420/ecr.2020.45
  • Views: Views 2270
  • Downloads: Downloads 208
  • Citations: 5